Finnrick, an independent testing programme, publishes 248 assays for Wuhan Wansheng Biotechnology: 173 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 75 did not. Most recent assay 22 Jul 2026.
Wuhan Wansheng Biotechnology operates from China, listed by Finnrick as "Trading". Source: Finnrick, https://www.finnrick.com/vendors/wuhan-wansheng-biotechnology.
Finnrick-tested with failing results. Tested across 9 peptide products with 213 total samples.
Wuhan Wansheng Biotechnology is listed as active. Finnrick Grade F. Finnrick avg score: 6.8/10 across 213 samples (9 products). Failing quality. Not recommended.
Wuhan Wansheng Biotechnology holds independent lab grade F, assigned across 213 graded samples, average score 6.8/10. That grade comes from an independent grader's own sampling, not from PeptideAtlas, and it describes the samples that grader obtained rather than every batch sold.
Community standing: 2.2/5 on Trustpilot from 21 reviews. Ratings of anonymous sellers of unregulated products are the weakest signal on this page; the assay and grading records carry more.
| Product | Assays | Result |
|---|---|---|
| Retatrutide | 70 | 60 passed, 10 failed |
| Tirzepatide | 52 | 46 passed, 6 failed |
| Tesamorelin | 26 | 6 passed, 20 failed |
| GHK-Cu | 22 | 20 passed, 2 failed |
| BPC-157 | 19 | 8 passed, 11 failed |
| Cagrilintide | 14 | 8 passed, 6 failed |
| Ipamorelin | 14 | 10 passed, 4 failed |
| TB-500 | 9 | 4 passed, 5 failed |
| CJC-1295 | 7 | 2 passed, 5 failed |
| Melanotan II | 6 | 4 passed, 2 failed |
| Semaglutide | 5 | 3 passed, 2 failed |
| PT-141 | 4 | 2 passed, 2 failed |
Source: Finnrick, as published 2026-08-09. Pass and fail are Finnrick's classification against its own threshold, not ours.
| Status | Active |
|---|---|
| Independent lab grade | F (213 samples) |
| Average grader score | 6.8/10 |
| Trustpilot | 2.2/5 from 21 reviews |
| Vendor type | Research-use supplier |
These details were read from Wuhan Wansheng Biotechnology's own website on 2026-08-10. Pages consulted:
Wuhan Wansheng Biotechnology is listed as active and we hold 248 Finnrick assays (173 passing, 75 failing its purity threshold); an independent lab grade of F. That is evidence about the batches that were tested or published, not a guarantee about the vial you receive.
Yes. Finnrick, an independent testing programme, publishes 248 assays for Wuhan Wansheng Biotechnology: 173 met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation) and 75 did not. Most recent assay 22 Jul 2026.
Similar vendors: Nantong Guangyuan Chemical GYC, Qingdao Sigma Chemical QSC, Shanghai Sigma Audley SSA.
Popular peptides: Semaglutide, Tirzepatide, Retatrutide, BPC-157, CJC-1295, Ipamorelin.
Other reviewed vendors: Xcel Peptides Review, Xiamen Jenny Chemical Technology Peptides Review, Xian Desheng yuan Biotechnology Peptides Review.